Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...

September 16, 2024--Updated results from the HIMALAYA Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab ... ADAURA ...

ADAURA Trail Results Reveal 79% Reduction in Risk of Death with Tagrisso The eagerly anticipated data from the Phase III ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

FluMist approved for self-administration in the US Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection FluMist ...

Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart ... Nucala gained nods from the FDA to treat ...

FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

FLUMIST ® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or ...

AstraZeneca is a company with a turbulent history ... Daiichi apparently declined the offer. Then, in early 2020, more rumours spread that AZ was looking to acquire Gilead, known for its high ...

In a first, the Food and Drug Administration on Friday approved AstraZeneca's FluMist, a nasal spray flu vaccine that anyone ...